Drug Trial Radar · NCT07488949
Doxycycline and Progestin Therapy for Chronic Endometritis(CE) in Patients With Recurrent Reproductive Failure(RRF)
Last checked: Nov 19, 2026Latest source record: Mar 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,000
Planned (sponsor's estimate)
Start
Apr 9, 2024
Primary completion
Dec 31, 2030
Study completion Dec 31, 2031
Sponsor
- Lead sponsor
- Fang WangAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 23, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 20 years, up to 45 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Prospective Randomized Controlled Trial, the goal of this clinical trial is to evaluate the efficacy and safety of doxycycline alone versus doxycycline plus medroxyprogesterone acetate (MPA) in women with chronic endometritis (CE), and to assess subsequent reproductive outcomes. Participants will be randomly assigned to one of two groups and will receive the assigned treatment. Participants will be followed for reproductive outcomes, including pregnancy , ongoing pregnancy, spontaneous miscarriage, and live birth.
Conditions
- Chronic Endometritis
Interventions
Doxycycline combined with MedroxyprogesteroneDrug
doxycycline 200 mg/day (100 mg twice daily) combined with medroxyprogesterone acetate(MPA) 24 mg/day (8 mg three times daily) for 14 days
Doxycycline combined with placeboDrug
doxycycline 200 mg/day (100 mg twice daily) with placebo 24 mg/day (8 mg three times daily) for 14 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cure rate of chronic endometritisTime frame: At 8 weeks after completion of treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Lanzhou University Second Hospital
Lanzhou, Gansu, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.